NO20033372D0 - Endotoksinbinding ved melkesyrebakterier og bifidobakterier - Google Patents

Endotoksinbinding ved melkesyrebakterier og bifidobakterier

Info

Publication number
NO20033372D0
NO20033372D0 NO20033372A NO20033372A NO20033372D0 NO 20033372 D0 NO20033372 D0 NO 20033372D0 NO 20033372 A NO20033372 A NO 20033372A NO 20033372 A NO20033372 A NO 20033372A NO 20033372 D0 NO20033372 D0 NO 20033372D0
Authority
NO
Norway
Prior art keywords
bifidobacteria
lactic acid
acid bacteria
endotoxin binding
endotoxin
Prior art date
Application number
NO20033372A
Other languages
English (en)
Other versions
NO20033372L (no
Inventor
Eduardo Schiffrin
Guillermo Kociubinski
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8179863&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20033372(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of NO20033372L publication Critical patent/NO20033372L/no
Publication of NO20033372D0 publication Critical patent/NO20033372D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
NO20033372A 2001-02-06 2003-07-28 Endotoksinbinding ved melkesyrebakterier og bifidobakterier NO20033372D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200436 2001-02-06
PCT/EP2002/001163 WO2002062360A1 (en) 2001-02-06 2002-02-01 Endotoxin binding by lactic acid bacteria and bifidobacteria

Publications (2)

Publication Number Publication Date
NO20033372L NO20033372L (no) 2003-07-28
NO20033372D0 true NO20033372D0 (no) 2003-07-28

Family

ID=8179863

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033372A NO20033372D0 (no) 2001-02-06 2003-07-28 Endotoksinbinding ved melkesyrebakterier og bifidobakterier

Country Status (20)

Country Link
US (2) US7550285B2 (no)
EP (1) EP1359924B1 (no)
JP (3) JP2004531477A (no)
KR (1) KR100845456B1 (no)
CN (1) CN1250232C (no)
AT (1) ATE375164T1 (no)
AU (1) AU2002250886B2 (no)
BR (1) BR0207019A (no)
CA (1) CA2436264C (no)
DE (1) DE60222856T2 (no)
EA (1) EA006397B1 (no)
ES (1) ES2292744T3 (no)
IL (1) IL157071A0 (no)
MX (1) MXPA03007024A (no)
NO (1) NO20033372D0 (no)
NZ (1) NZ527493A (no)
PL (1) PL367083A1 (no)
PT (1) PT1359924E (no)
WO (1) WO2002062360A1 (no)
ZA (1) ZA200306935B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100845456B1 (ko) * 2001-02-06 2008-07-10 소시에떼 데 프로듀이 네슬레 소시에떼아노님 젖산균 및 비피도균에 의한 내독소 결합
FR2848115B1 (fr) * 2002-12-05 2005-03-25 Rhodia Chimie Sa Composition de bacteries et son utilisation
SE526711C2 (sv) * 2003-01-31 2005-10-25 Probi Ab Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
ATE512211T1 (de) 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
US20090083067A1 (en) * 2006-03-29 2009-03-26 Mary Elaine Freeland Methods and kits for selecting a health care product
EP2124966B1 (en) 2007-02-01 2015-09-09 IAMS Europe B.V. Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
WO2008106373A1 (en) * 2007-02-28 2008-09-04 Mead Johnson Nutrition Company Product containing inactivated probiotic for children or infants
KR100913406B1 (ko) * 2008-03-25 2009-08-21 광주과학기술원 Ｔｈ１－매개 면역 질환의 예방 또는 치료용 조성물
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
EP2459203B1 (en) * 2009-07-30 2018-10-31 DuPont Nutrition Biosciences ApS Lactic acid bacteria and bifidobacteria for treating endotoxemia
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011069860A1 (en) 2009-12-08 2011-06-16 Chr. Hansen A/S Novel use for the treatment of metabolic endotoxemia
JP2010280664A (ja) * 2010-07-02 2010-12-16 Biogaia Ab ラクトバチルス・リューテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ）株を用いる哺乳類における免疫機能の改善方法
HK1200062A1 (en) 2011-07-13 2015-07-31 弗里斯兰品牌有限公司 Dairy based compositions with low lps
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
IN2014DN07752A (no) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
WO2015048511A1 (en) * 2013-09-30 2015-04-02 Elc Management Llc Watery lotion skin care compositions and methods
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
CN104498375B (zh) * 2014-12-02 2017-05-10 江南大学 一株具有内毒素吸附特性的耶氏酵母及其吸附特性研究方法
JP6710075B2 (ja) * 2016-03-29 2020-06-17 カゴメ株式会社 Ｌｐｓ産生抑制剤、及びｌｐｓ産生抑制用の食品組成物
TWI640319B (zh) * 2017-05-12 2018-11-11 健茂生物科技股份有限公司 具有抗發炎活性之醱酵液的製備方法
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
CA3106315A1 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
JP6888145B2 (ja) * 2020-03-23 2021-06-16 カゴメ株式会社 Ｌｐｓ産生抑制剤、及びｌｐｓ産生抑制用の食品組成物
WO2021253017A2 (en) * 2020-06-07 2021-12-16 Ramasamy Sundaram Compositions and methods for detoxifying bacterial endotoxins and hydrogen sulfide by recombinant fusion enzymes
US20230323332A1 (en) 2020-08-28 2023-10-12 Chr. Hansen A/S Microencapsulation of microbial culture using octenyl succinic anhydride starch-chitosan complex coacervate
WO2022171203A1 (zh) * 2021-02-10 2022-08-18 中科微智（北京）生物科技有限公司 一种乳双歧杆菌及其应用
WO2025202427A1 (en) 2024-03-28 2025-10-02 Chr. Hansen A/S Microencapsulated microbial culture using protein-carbohydrate and chitosan complex coacervate polymer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US555618A (en) * 1896-03-03 Hay-loader
IT1254210B (it) * 1992-02-10 1995-09-14 Simone Claudio De Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego
US5413785A (en) * 1993-01-27 1995-05-09 New England Deaconess Hospital Corp. Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
JP2506314B2 (ja) * 1993-10-27 1996-06-12 全国農業協同組合連合会 家禽・豚の敗血症の予防・治療剤及び飼料
US6506389B2 (en) * 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
DE69707413T3 (de) * 1997-01-09 2009-07-02 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
JP4163276B2 (ja) * 1998-02-05 2008-10-08 独立行政法人理化学研究所 機能性組成物
US6368591B2 (en) 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
EP1137423B1 (en) * 1998-12-11 2005-03-09 Urex Biotech, Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
MXPA02009342A (es) * 2000-03-24 2003-09-22 Nestle Sa Uso de bacterias de acido lactico para el tratamiento de la peritonitis.
KR100845456B1 (ko) * 2001-02-06 2008-07-10 소시에떼 데 프로듀이 네슬레 소시에떼아노님 젖산균 및 비피도균에 의한 내독소 결합

Also Published As

Publication number Publication date
US7550285B2 (en) 2009-06-23
DE60222856T2 (de) 2008-07-24
EA006397B1 (ru) 2005-12-29
EP1359924A1 (en) 2003-11-12
NZ527493A (en) 2005-06-24
BR0207019A (pt) 2004-02-25
PT1359924E (pt) 2007-12-07
AU2002250886B2 (en) 2007-08-02
CN1501805A (zh) 2004-06-02
EP1359924B1 (en) 2007-10-10
EA200300862A1 (ru) 2003-12-25
KR20030076652A (ko) 2003-09-26
ZA200306935B (en) 2004-12-06
CN1250232C (zh) 2006-04-12
HK1066174A1 (en) 2005-03-18
JP2011246483A (ja) 2011-12-08
US20100136662A1 (en) 2010-06-03
ATE375164T1 (de) 2007-10-15
ES2292744T3 (es) 2008-03-16
IL157071A0 (en) 2004-02-08
US7964384B2 (en) 2011-06-21
NO20033372L (no) 2003-07-28
JP2014062104A (ja) 2014-04-10
CA2436264C (en) 2014-01-28
DE60222856D1 (de) 2007-11-22
MXPA03007024A (es) 2003-11-18
KR100845456B1 (ko) 2008-07-10
WO2002062360A1 (en) 2002-08-15
PL367083A1 (en) 2005-02-21
CA2436264A1 (en) 2002-08-15
US20040115178A1 (en) 2004-06-17
JP5973701B2 (ja) 2016-08-23
JP2004531477A (ja) 2004-10-14

Similar Documents

Publication Publication Date Title
NO20033372D0 (no) Endotoksinbinding ved melkesyrebakterier og bifidobakterier
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
EP2341063A3 (en) Novel immunogenic compositions for the prevention and treatment of meningococcal disease
WO2002085857A3 (en) Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
IL147271A0 (en) Compounds that bind her2
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
IL195142A (en) Processed arylaimidazolone and triazolone, their preparation process, pharmaceutical preparations containing them for the treatment or prevention of diseases
WO2003099110A3 (en) Herbs and herbal combinations useful for the treatment of microbial infections
WO2008148873A3 (en) Hydroxyproline compositions and uses thereof
WO2001052667A3 (en) Pet food composition for treating helicobacter species in pets
WO2007016538A3 (en) Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
MY148286A (en) Freeze-dried, aerated dairy or dairy-substitute compositions and methods of making thereof
WO2005116088A3 (en) Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells
BR0214902A (pt) Preparação bacteriana, frações de preparação bacteriana, composição farmacêutica, uso da preparação bacteriana ou suas frações, método para a produção da preparação de bactérias mortas liofilizadas estendidas, kit para o tratamento de uma doença compreendendo uma desregulação imune, e, produtos
BRPI0409609A (pt) mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
IL141325A0 (en) Tan-1057 derivatives
WO2004110373A3 (en) Therapeutic vaccine compositions for the treatment of type 1 diabetes
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
DE60235418D1 (de) Osteoprotegerin in Milch
EP1608352A4 (en) POLYAMINE COMPOUNDS FOR THE TREATMENT OF CHEMOKINE-RECEPTOR INDUCED DISEASES
WO2003026693A3 (en) Inhibitors of costimulation by 0x40 and their use against infectious diseases
WO2006129092A3 (en) Use of bacteriophage in medicaments
WO2007030708A3 (en) Antimicrobial adzymes and uses thereof
EP1548445A3 (en) Novel targets for obesity from fat tissue

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application